RT Journal Article
SR Electronic
T1 LGI1 Is a Nogo Receptor 1 Ligand that Antagonizes Myelin-Based Growth Inhibition
JF The Journal of Neuroscience
JO J. Neurosci.
FD Society for Neuroscience
SP 6607
OP 6612
DO 10.1523/JNEUROSCI.5147-09.2010
VO 30
IS 19
A1 Thomas, Rhalena
A1 Favell, Kristy
A1 Morante-Redolat, Jose
A1 Pool, Madeline
A1 Kent, Christopher
A1 Wright, Melissa
A1 Daignault, Kathleen
A1 Ferraro, Gino B.
A1 Montcalm, Samuel
A1 Durocher, Yves
A1 Fournier, Alyson
A1 Perez-Tur, Jordi
A1 Barker, Philip A.
YR 2010
UL http://www.jneurosci.org/content/30/19/6607.abstract
AB Mutations in leucine-rich glioma inactivated (LGI1) are a genetic cause of autosomal dominant temporal lobe epilepsy with auditory features. LGI1 is a secreted protein that shares homology with members of the SLIT family, ligands that direct axonal repulsion and growth cone collapse, and we therefore considered the possibility that LGI1 may regulate neuronal process extension or growth cone collapse. Here we report that LGI1 does not affect growth directly but instead enhances neuronal growth on myelin-based inhibitory substrates and antagonizes myelin-induced growth cone collapse. We show that LGI1 mediates this effect by functioning as a specific Nogo receptor 1 (NgR1) ligand that antagonizes the action of myelin-based inhibitory cues. Finally, we demonstrate that NgR1 and ADAM22 physically associate to form a receptor complex in which NgR1 facilitates LGI1 binding to ADAM22.